| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |